Tanushree Sahoo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Tanushree Sahoo has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
Krishna Mohan Gulla
Department of Pediatrics, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
5 shared publicationsPurbasha Mishra
Department of Neonatology, AIIMS, Bhubaneswar, Odisha, India
5 shared publications- Tapas Kumar Som
Department of Neonatology AIIMS Bhubaneswar Odisha India
5 shared publications - Pankaj Kumar Mohanty
Department of Neonatology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
4 shared publications - Usha Devi
Neonatology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
4 shared publications Pankaj Kumar Mohanty
Neonatology, All India Institute of Medical Sciences, Bhubaneswar, Bhubaneswar, IND
3 shared publications
Latest Publications
- 25 August 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (9)
Less Invasive Surfactant Administration Using Video Laryngoscope to Decrease Pain in Neonates: A Randomized Controlled Trial
Objectives: To assess whether the use of video laryngoscope, when compared to conventional laryngoscope decreases pain (assessed by Faceless Acute Neonatal Pain Scale) in preterm neonates while administering surfactant by LISA. Methods: Preterm neonates < 35 weeks requiring FiO 2 > 0.3 on CPAP pressure of at least 6 cm of H 2 O were administered surfactant by LISA technique either by video laryngoscope (Intervention) or conventional laryngoscope (Control). Faceless Acute Neonatal Pain Scale was used to determine pain 5 min before the procedure, immediately, 5 min, and 10 min after the procedure. The primary outcome was severity of pain; secondary outcomes were time taken to complete the procedure, number of attempts, incidence of IVH, and adverse events during the procedure. Results: In total, 42 neonates of < 35 weeks gestation with comparable baseline demographics were randomized into 2 groups. The median (IQR) FANS score immediately post‐procedure in the intervention arm was 2 (2–4) versus 2 (1–4) in the control arm, p = 0.79. There was no statistical difference in the secondary outcomes studied. Conclusion: The two groups had no difference in the pain score. The pain experienced by neonates during the LISA procedure was moderate and of short duration and it did not depend on the type of laryngoscope used. Moderate pain during the procedure can be managed with nonpharmacological measures; thereby, the use of sedatives or analgesics can be avoided, which might be of concern. There was no difference in the number of attempts or in time taken to complete the procedure when performed by neonatologists experienced in using conventional laryngoscopes compared to video laryngoscopes. Trial Registration: Clinical Trial Registry of India: CTRI/2022/09/045204 on 05.09.2022.
- 25 August 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (9)
Less Invasive Surfactant Administration Using Video Laryngoscope to Decrease Pain in Neonates: A Randomized Controlled Trial
Objectives: To assess whether the use of video laryngoscope, when compared to conventional laryngoscope decreases pain (assessed by Faceless Acute Neonatal Pain Scale) in preterm neonates while administering surfactant by LISA. Methods: Preterm neonates < 35 weeks requiring FiO 2 > 0.3 on CPAP pressure of at least 6 cm of H 2 O were administered surfactant by LISA technique either by video laryngoscope (Intervention) or conventional laryngoscope (Control). Faceless Acute Neonatal Pain Scale was used to determine pain 5 min before the procedure, immediately, 5 min, and 10 min after the procedure. The primary outcome was severity of pain; secondary outcomes were time taken to complete the procedure, number of attempts, incidence of IVH, and adverse events during the procedure. Results: In total, 42 neonates of < 35 weeks gestation with comparable baseline demographics were randomized into 2 groups. The median (IQR) FANS score immediately post‐procedure in the intervention arm was 2 (2–4) versus 2 (1–4) in the control arm, p = 0.79. There was no statistical difference in the secondary outcomes studied. Conclusion: The two groups had no difference in the pain score. The pain experienced by neonates during the LISA procedure was moderate and of short duration and it did not depend on the type of laryngoscope used. Moderate pain during the procedure can be managed with nonpharmacological measures; thereby, the use of sedatives or analgesics can be avoided, which might be of concern. There was no difference in the number of attempts or in time taken to complete the procedure when performed by neonatologists experienced in using conventional laryngoscopes compared to video laryngoscopes. Trial Registration: Clinical Trial Registry of India: CTRI/2022/09/045204 on 05.09.2022.
- 10 February 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (2) , e267688
From consanguinity to crisis: a rare cause of neonatal encephalopathy
Carbamoyl phosphate synthetase 1 (CPS-1) deficiency is a rare autosomal recessive disorder that disrupts the proximal mitochondrial phase of the urea cycle, resulting in impaired ureagenesis, hyperammonaemia and metabolic decompensation during the neonatal period. This condition is linked to significant neurological impairment and poses a considerable risk of mortality, especially in newborns. This case underscores the importance of recognising urgent clinical presentation and the intricate management challenges encountered in the treatment of early-onset CPS-1 deficiency.
- 10 February 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (2) , e267688
From consanguinity to crisis: a rare cause of neonatal encephalopathy
Carbamoyl phosphate synthetase 1 (CPS-1) deficiency is a rare autosomal recessive disorder that disrupts the proximal mitochondrial phase of the urea cycle, resulting in impaired ureagenesis, hyperammonaemia and metabolic decompensation during the neonatal period. This condition is linked to significant neurological impairment and poses a considerable risk of mortality, especially in newborns. This case underscores the importance of recognising urgent clinical presentation and the intricate management challenges encountered in the treatment of early-onset CPS-1 deficiency.
- Open Access
- 21 January 2026
- Published by Springer Nature in Cureus
- Vol. 18 (1)
Neonatal Purpura Fulminans: An Unusual Cause of Leukocoria, Retinal Detachment, and Vitreous Hemorrhage in Neonates
Neonatal purpura fulminans is a rare but life-threatening thrombotic disorder caused by congenital deficiencies of protein C. It presents with hemorrhagic necrosis of the skin due to the underlying dysfunction of coagulation. Ocular findings include leukocoria, chemosis, periorbital edema, posterior synechia, vitreous hemorrhage, retinal detachment, and retinal dysplasia. Sometimes, leukocoria may occur before any other manifestations. Here, we describe a case of neonatal purpura fulminans characterized by multiple purpuric skin lesions, leukocoria, vitreous hemorrhage, and total retinal detachment.
- 21 January 2026
- Published by Springer Nature in Cureus
- Vol. 18 (1)
Open AccessNeonatal Purpura Fulminans: An Unusual Cause of Leukocoria, Retinal Detachment, and Vitreous Hemorrhage in Neonates
Neonatal purpura fulminans is a rare but life-threatening thrombotic disorder caused by congenital deficiencies of protein C. It presents with hemorrhagic necrosis of the skin due to the underlying dysfunction of coagulation. Ocular findings include leukocoria, chemosis, periorbital edema, posterior synechia, vitreous hemorrhage, retinal detachment, and retinal dysplasia. Sometimes, leukocoria may occur before any other manifestations. Here, we describe a case of neonatal purpura fulminans characterized by multiple purpuric skin lesions, leukocoria, vitreous hemorrhage, and total retinal detachment.
- 20 November 2025
- Published by SAGE Publications in Tropical Doctor
- Vol. 56 (2) , 284-287
Clinical profile and predictors of biochemical markers of metabolic bone disease in very preterm neonates: An observational study
Metabolic bone disease (MBD) is a significant concern in very preterm neonates, with clinical signs often delayed compared to biochemical and radiological markers. MBD was defined as serum phosphate 600 IU/L or alkaline phosphatase >1000 IU/L. Key risk factors included lower gestational age, lower birth weight, prolonged total parenteral nutrition, delayed attainment of full enteral feeding (>7 days), cholestasis, bronchopulmonary dysplasia, and anaemia requiring transfusion. Logistic regression identified delayed attainment of full enteral feeding (>7 days) as a significant predictor for developing MBD.
- 20 November 2025
- Published by SAGE Publications in Tropical Doctor
- Vol. 56 (2) , 284-287
Clinical profile and predictors of biochemical markers of metabolic bone disease in very preterm neonates: An observational study
Metabolic bone disease (MBD) is a significant concern in very preterm neonates, with clinical signs often delayed compared to biochemical and radiological markers. MBD was defined as serum phosphate 600 IU/L or alkaline phosphatase >1000 IU/L. Key risk factors included lower gestational age, lower birth weight, prolonged total parenteral nutrition, delayed attainment of full enteral feeding (>7 days), cholestasis, bronchopulmonary dysplasia, and anaemia requiring transfusion. Logistic regression identified delayed attainment of full enteral feeding (>7 days) as a significant predictor for developing MBD.
- Open Access
- 6 July 2024
- Published by Medknow in Journal of Indian Association of Pediatric Surgeons
- Vol. 29 (4) , 393-394
Biliary Perforation in a Neonate – A Rare Cause of Infantile Cholestasis
- 6 July 2024
- Published by Medknow in Journal of Indian Association of Pediatric Surgeons
- Vol. 29 (4) , 393-394
Open AccessBiliary Perforation in a Neonate – A Rare Cause of Infantile Cholestasis
- 22 April 2024
- Published by SAGE Publications in Journal of Neonatology
- Vol. 38 (2) , 235-240
Knowledge, Attitude, and Practices Toward Kangaroo Mother Care Among Mothers in a Tertiary Neonatal Care Unit
Aim: To study the knowledge, attitude, and practices of Kangaroo Mother Care ( KMC) among eligible postnatal mothers in the postnatal ward (PNW) and neonatal intensive care unit (NICU) of a tertiary neonatal unit in Eastern India. Methods: A cross-sectional survey was conducted among 100 mothers of low-birth-weight babies in our PNW and NICU. As part of the unit protocol, all mothers of eligible babies were counseled about KMC at first contact verbally as well as by using an informative video on KMC. Data was collected using a structured questionnaire after the routine counseling of the mothers on their first visit after delivery. The analysis of the data was done using appropriate statistics. Results: More than three-fourths (83.2%) of mothers had good knowledge of KMC. A good attitude toward using KMC was found in 91.6% of the mothers. Almost all the mothers (98%) knew the correct KMC position, and 12% of mothers had a previous preterm baby and had given KMC. Many mothers felt the small size of the baby, pain after cesarean section, and central or peripheral intravenous lines in the baby were barriers to KMC. Conclusion: The knowledge regarding KMC among mothers whose babies were admitted into the PNW/NICU was good. Though the attitude toward KMC was good, mothers felt there were multiple barriers to initiating KMC.
- 22 April 2024
- Published by SAGE Publications in Journal of Neonatology
- Vol. 38 (2) , 235-240
Knowledge, Attitude, and Practices Toward Kangaroo Mother Care Among Mothers in a Tertiary Neonatal Care Unit
Aim: To study the knowledge, attitude, and practices of Kangaroo Mother Care ( KMC) among eligible postnatal mothers in the postnatal ward (PNW) and neonatal intensive care unit (NICU) of a tertiary neonatal unit in Eastern India. Methods: A cross-sectional survey was conducted among 100 mothers of low-birth-weight babies in our PNW and NICU. As part of the unit protocol, all mothers of eligible babies were counseled about KMC at first contact verbally as well as by using an informative video on KMC. Data was collected using a structured questionnaire after the routine counseling of the mothers on their first visit after delivery. The analysis of the data was done using appropriate statistics. Results: More than three-fourths (83.2%) of mothers had good knowledge of KMC. A good attitude toward using KMC was found in 91.6% of the mothers. Almost all the mothers (98%) knew the correct KMC position, and 12% of mothers had a previous preterm baby and had given KMC. Many mothers felt the small size of the baby, pain after cesarean section, and central or peripheral intravenous lines in the baby were barriers to KMC. Conclusion: The knowledge regarding KMC among mothers whose babies were admitted into the PNW/NICU was good. Though the attitude toward KMC was good, mothers felt there were multiple barriers to initiating KMC.
- Open Access
- 14 February 2024
- Published by Springer Nature in Cureus
- Vol. 16 (2) , e54219
Transient Abnormal Myelopoiesis: An Abnormal Course and the Efficacy of Delayed Treatment
Transient abnormal myelopoiesis (TAM) is observed in a few neonates with Down syndrome. While a large proportion undergo complete remission without any treatment, some of them can develop myeloid leukemia of Down syndrome (ML-DS) in the future. Without proper treatment, mortality can be high. Here we have described an interesting and difficult-to-treat case of a neonatal with Down syndrome who presented with anemia, thrombocytopenia, and 75% blasts. We came across multiple challenges in treatment due to severe pneumonia.
- 14 February 2024
- Published by Springer Nature in Cureus
- Vol. 16 (2) , e54219
Open AccessTransient Abnormal Myelopoiesis: An Abnormal Course and the Efficacy of Delayed Treatment
Transient abnormal myelopoiesis (TAM) is observed in a few neonates with Down syndrome. While a large proportion undergo complete remission without any treatment, some of them can develop myeloid leukemia of Down syndrome (ML-DS) in the future. Without proper treatment, mortality can be high. Here we have described an interesting and difficult-to-treat case of a neonatal with Down syndrome who presented with anemia, thrombocytopenia, and 75% blasts. We came across multiple challenges in treatment due to severe pneumonia.
- 28 November 2023
- Published by SAGE Publications in Journal of Neonatology
- Vol. 38 (3) , 460-462
Management of Respiratory Distress Syndrome: Clinical Implications from Recent European Consensus Guidelines
Respiratory distress syndrome (RDS) is the most common major morbidity in preterm infants. The recent 6th edition of European consensus guidelines (2023) on RDS gives comprehensive care pathways for management of this vulnerable population based on updated evidence until the end of 2022. The current update also aims to highlight the major updates from the previous version (2019) and to compare the surfactant and non-invasive respiratory support guidelines from the National Neonatology Forum, India.
- 28 November 2023
- Published by SAGE Publications in Journal of Neonatology
- Vol. 38 (3) , 460-462
Management of Respiratory Distress Syndrome: Clinical Implications from Recent European Consensus Guidelines
Respiratory distress syndrome (RDS) is the most common major morbidity in preterm infants. The recent 6th edition of European consensus guidelines (2023) on RDS gives comprehensive care pathways for management of this vulnerable population based on updated evidence until the end of 2022. The current update also aims to highlight the major updates from the previous version (2019) and to compare the surfactant and non-invasive respiratory support guidelines from the National Neonatology Forum, India.
- 14 September 2023
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 43 (1) , 63-68
Elizabethkingia meningoseptica Outbreak in NICU: An Observational Study on a Debilitating Neuroinfection in Neonates
Background: Elizabethkingia meningoseptica is an emerging nosocomial pathogen implicated in neonatal sepsis with high mortality and morbidities. However, there is very limited data regarding the characteristics as well as outcomes following this infection, particularly in developing countries. Methods: We conducted a retrospective observational study of all infants with culture-positive Elizabethkingia sepsis as part of an outbreak, to study their clinical and epidemiological characteristics, as well as their antimicrobial susceptibility patterns, using a structured proforma from the neonatal intensive care unit database. Analysis was done using descriptive statistics and predictors of mortality and hydrocephalus were also identified. Results: Of the 21 neonates enrolled, 9 (42.9%) were male, with a mean gestational age and birth weight of 31.7 ± 3.4 weeks and 1320 ± 364 g, respectively. The median (interquartile range) age of onset of illness was 7 (5–12) days. The overall mortality rate was 23.8%, and among survivors, 50% had neurologic complications requiring intervention. Vancomycin and ciprofloxacin were the most used antibiotics for treatment in our series, with a median duration of 26 (17–38) days. On univariate analysis, shock at presentation was significantly associated with increased mortality (P = 0.04) while, seizures (P = 0.04) and elevated cerebrospinal fluid protein levels (P = 0 .01) at onset of illness predicted progressive hydrocephalus in surviving neonates. Conclusion: E. meningoseptica sepsis is associated with high morbidity and mortality. Early diagnosis and prompt initiation of appropriate antibiotics are critical for improving survival and neurodevelopmental outcomes. Though isolation of the organism by environmental surveillance is always not possible, with proper infection control measures, the infection can be controlled.
- 14 September 2023
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 43 (1) , 63-68
Elizabethkingia meningoseptica Outbreak in NICU: An Observational Study on a Debilitating Neuroinfection in Neonates
Background: Elizabethkingia meningoseptica is an emerging nosocomial pathogen implicated in neonatal sepsis with high mortality and morbidities. However, there is very limited data regarding the characteristics as well as outcomes following this infection, particularly in developing countries. Methods: We conducted a retrospective observational study of all infants with culture-positive Elizabethkingia sepsis as part of an outbreak, to study their clinical and epidemiological characteristics, as well as their antimicrobial susceptibility patterns, using a structured proforma from the neonatal intensive care unit database. Analysis was done using descriptive statistics and predictors of mortality and hydrocephalus were also identified. Results: Of the 21 neonates enrolled, 9 (42.9%) were male, with a mean gestational age and birth weight of 31.7 ± 3.4 weeks and 1320 ± 364 g, respectively. The median (interquartile range) age of onset of illness was 7 (5–12) days. The overall mortality rate was 23.8%, and among survivors, 50% had neurologic complications requiring intervention. Vancomycin and ciprofloxacin were the most used antibiotics for treatment in our series, with a median duration of 26 (17–38) days. On univariate analysis, shock at presentation was significantly associated with increased mortality (P = 0.04) while, seizures (P = 0.04) and elevated cerebrospinal fluid protein levels (P = 0 .01) at onset of illness predicted progressive hydrocephalus in surviving neonates. Conclusion: E. meningoseptica sepsis is associated with high morbidity and mortality. Early diagnosis and prompt initiation of appropriate antibiotics are critical for improving survival and neurodevelopmental outcomes. Though isolation of the organism by environmental surveillance is always not possible, with proper infection control measures, the infection can be controlled.
- 23 May 2023
- Published by SAGE Publications in Journal of Neonatology
- Vol. 37 (4) , 334-339
Spectrum of Cytomegalovirus (CMV) Infection from a Tertiary Care Neonatal ICU in Resource Limited Settings
Cytomegalovirus (CMV) infection is the most common viral infection in perinatal period, which can occur in neonates from mother, in utero (congenital) via placenta, during birth from birth canal or more commonly postnatally from maternal breast milk or blood product transmission. In premature infants in many instances it can lead to severe manifestations resulting in increased morbidities and mortality. In this case series we share our experience on the clinicodemographic profile for CMV infections in neonatal intensive care unit and subsequent challenges related to its early detection and timely treatment in resource limited settings.
- 23 May 2023
- Published by SAGE Publications in Journal of Neonatology
- Vol. 37 (4) , 334-339
Spectrum of Cytomegalovirus (CMV) Infection from a Tertiary Care Neonatal ICU in Resource Limited Settings
Cytomegalovirus (CMV) infection is the most common viral infection in perinatal period, which can occur in neonates from mother, in utero (congenital) via placenta, during birth from birth canal or more commonly postnatally from maternal breast milk or blood product transmission. In premature infants in many instances it can lead to severe manifestations resulting in increased morbidities and mortality. In this case series we share our experience on the clinicodemographic profile for CMV infections in neonatal intensive care unit and subsequent challenges related to its early detection and timely treatment in resource limited settings.